Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Agenus logo — company profile

Agenus

Founded 1994 United States Lexington, United States 291 employees Post Ipo Debt Total: $346.14M Biotechnology, Health and Wellness +1

General Information

Company Name Agenus
Founded Year 1994
Location United States Lexington, United States +1
Founders / Decision Makers
Team member Team member
Employees 291
Industries Biotechnology, Health and Wellness, Medical Devices
Funding Stage Post Ipo Debt
Social

Get notified when Agenus moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company, founded in 1994 and headquartered in Lexington, MA, aims to expand patient populations benefiting from cancer immunotherapy through combination approaches. Agenus utilizes a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics), and adjuvants (through SaponiQx). The company received a significant $40.00M Post-IPO Equity investment on 11 October 2018. Agenus' mission to contribute to the field of biotechnology by focusing on immunological solutions for cancer and infectious diseases is noteworthy. For further information regarding Agenus, please visit their website at www.agenusbio.com or follow them at @agenus_bio. Additionally, the company's Community Guidelines are available at their website and at: https://agenusbio.com/community-guidelines/.

Taxonomy: Immuno-oncology, Cancer Vaccines, Checkpoint Inhibitors, Immunotherapy, Cell therapy, Antibodies, GMP Manufacturing

Funding Rounds & Investors (8)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Debt •••••• 1 •••• •••• 07 May 2024
Post-IPO Equity •••••• - 11 Oct 2018
Post-IPO Equity •••••• 1
Investor
14 Feb 2017
Post-IPO Debt •••••• - 23 Sep 2015
Post-IPO Debt •••••• - 11 Mar 2015

View All 8 Funding Rounds

Agenus Alternatives & Competitors

Agenus vs
Allogene Therapeutics
Allogene Therapeutics United States

A biotechnology company catalyzing cancer treatment through the development of CAR T therapy

IPO
214 employees
Biotechnology
Compare Agenus vs Allogene Therapeutics
Agenus vs
ITM Isotope Technologies Munich SE
ITM Isotope Technologies Munich SE Germany

Delivering the promise of radiopharmaceuticals to patients.

Private Equity
648 employees
Biopharma, Biotechnology
Compare Agenus vs ITM Isotope Technologies Munich SE
Agenus vs
Merus N.V.
Merus N.V. The Netherlands

Oncology company developing Biclonics® bispecific antibody therapeutics. See our Community Guideline...

Post Ipo Equity
253 employees
Biotechnology, Health Care
Compare Agenus vs Merus N.V.

FAQ About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody...
Agenus was founded in 1994.
Agenus is headquartered in Lexington, United States.
Agenus operates in the following industries: Biotechnology, Health and Wellness, Medical Devices.
Agenus has approximately 291 employees.
Agenus has completed 8 funding rounds, raising a total of $346.14M. The latest funding stage is Post Ipo Debt.
Top alternatives and competitors to Agenus include Allogene Therapeutics, ITM Isotope Technologies Munich SE, Merus N.V., Kronos Bio, Stelexis BioSciences, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Agenus and Allogene Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Agenus and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy